american society of hematology

April 21, 2022

Biltibo receives career development award to support hematology research

Vanderbilt’s Eden Biltibo, MD, a clinical fellow in the Division of Hematology and Oncology, has been selected for the 2022 ASH-CIBMTR-ASTCT Career Development Award.

By Tom Wilemon
July 29, 2019

DeBaun’s mentoring honored by American Society of Hematology

Michael DeBaun, MD, MPH, has been awarded the American Society of Hematology’s 2019 ASH Mentor Award for his sustained and outstanding commitment to the training and career development of early career hematologists.

By Christina Echegaray
January 31, 2019

Cell death pathway implicated in bone marrow failure

Vanderbilt investigators have linked a specific form of programmed cell death to myelodysplastic syndrome, a type of bone marrow failure.

By Leigh MacMillan
young african american man in hospital
February 22, 2017

Risk of death in sickle cell disease

Two factors commonly used to evaluate patients with sickle cell disease are associated with each other and can predict increased mortality, Vanderbilt researchers have discovered.

By Meredith Jackson
July 13, 2015

Hhex on cancer

A new mouse model demonstrates that the Hhex gene – which is linked to blood cancers – is critical for normal blood cell production.

By Henry H. Ong
August 14, 2014

DeBaun’s sickle cell disease research honored

Michael R. DeBaun, M.D., MPH, has been recognized by the American Society of Hematology (ASH) for his significant contributions and research advances in the area of sickle cell disease.

By Christina Echegaray
August 22, 2013

VU investigators land ‘bridge grants’ from hematology society

Utpal Davé, M.D., and Sandra Zinkel, M.D., Ph.D., have each received one-year, $100,000 “bridge grants” from the American Society of Hematology (ASH) to support research that has not been funded by the National Institutes of Health (NIH) due to budget cuts.
By Bill Snyder